ProfileGDS5822 / ILMN_2598876
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 17% 32% 41% 7% 29% 8% 21% 11% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 112.117
GSM1276600PDAC Late Ablation Control 217.832
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 116.441
GSM1276603PDAC Late Ablation 27.47
GSM1276604PDAC Late Ablation 315.129
GSM1303940PDAC Late Ablation_anti-CTLA4 18.98
GSM1303941PDAC Late Ablation_anti-CTLA4 211.121
GSM1303942PDAC Late Ablation_anti-CTLA4 36.811